SCHEMBL3386730

SCHEMBL3386730

Nc1cccc(-c2ccc3c(C(=O)O)n[nH]c3c2)c1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.67
AAK1 Q2M2I8 2/20 0.58
JAK2 O60674 1/20 0.54
PRKAG1 P54619 10/20 0.52
PRKAA1 Q13131 10/20 0.52
PRKAB1 Q9Y478 10/20 0.52
PRKAB2 O43741 9/20 0.52
PRKAA2 P54646 9/20 0.52
PRKAG3 Q9UGI9 9/20 0.52
PRKAG2 Q9UGJ0 9/20 0.52
MCL1 Q07820 1/20 0.48
AURKA O14965 1/20 0.48
TTK P33981 1/20 0.45
FGFR1 P11362 1/20 0.45
FGFR2 P21802 1/20 0.45
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3380509 0.87 FGFR1 (0.58) PDPK1JAK2PRKAG1PRKAA1PRKAB1
SCHEMBL3387378 0.84 PDPK1 (0.60) PDPK1AAK1JAK2PRKAG1PRKAA1
SCHEMBL2919160 0.84 PRKAG1 (0.48) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL3385023 0.81 KDM4E (0.60) PDPK1AAK1JAK2FGFR1FGFR2
SCHEMBL12907253 0.81 PDPK1 (1.00) PDPK1AAK1JAK2AURKAFGFR1
SCHEMBL14699223 0.80 GSK3B (0.58) PDPK1JAK2PRKAG1PRKAA1PRKAB1
SCHEMBL3384896 0.79 PRKAG1 (0.49) JAK2PRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL13337374 0.78 PRKAG1 (0.53) AAK1JAK2PRKAG1PRKAA1PRKAB1
SCHEMBL5945655 0.78 PRKAA1 (0.72) JAK2PRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL4008217 0.76 PRKAG1 (0.56) JAK2PRKAG1PRKAA1PRKAB1PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102239150-A Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient KOREA INST SCI & TECH 2011-11-09 CN claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
CN-102239150-A Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient KOREA INST SCI & TECH 2011-11-09 CN disclosed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed